Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 12/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 8/20 | 0.57 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.57 |
| ▸ | MME | P08473 | 1/20 | 0.53 |
| ▸ | ACE | P12821 | 1/20 | 0.49 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.48 |
| ▸ | CCKAR | P32238 | 1/20 | 0.48 |
| ▸ | CCKBR | P32239 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29895656 | 0.91 | NAALAD2 (0.53) | OPRD1OPRM1OPRK1MMENAALAD2 | |
| SCHEMBL30445825 | 0.89 | OPRD1 (0.52) | OPRD1OPRM1OPRK1MME | |
| SCHEMBL29871876 | 0.89 | OPRD1 (0.49) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29379340 | 0.89 | NAALAD2 (0.59) | OPRD1OPRM1OPRK1ACENAALAD2 | |
| SCHEMBL31031528 | 0.89 | NAALAD2 (0.55) | OPRD1OPRM1OPRK1NAALAD2 | |
| SCHEMBL30987807 | 0.88 | BACE1 (0.53) | OPRD1OPRM1OPRK1NAALAD2 | |
| SCHEMBL30163211 | 0.87 | NAALAD2 (0.56) | MMEACENAALAD2 | |
| SCHEMBL29531430 | 0.87 | NAALAD2 (0.62) | OPRM1MMEACENAALAD2 | |
| SCHEMBL31644070 | 0.86 | OPRD1 (0.62) | OPRD1OPRM1OPRK1MMEACE | |
| SCHEMBL30880911 | 0.84 | NAALAD2 (0.57) | OPRD1OPRM1OPRK1NAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025133708-A2 | THERAPEUTIC USE OF COMPOSITIONS AND METHODS FOR EPIDERMAL TREATMENT | SPECBIO, INC. (US) | 2025-06-26 | — | — | WO | disclosed |